Lexicon Pharma (LXRX) Tops Q1 EPS by 1c

Lexicon Pharma (NASDAQ: LXRX) reported Q1 EPS of ($0.21), $0.01 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $9.22 million versus the consensus estimate of $13.27 million.

For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.

You May Also Be Interested In

• Phillip Securities Reiterates Buy Rating on Sea Ltd. (SE)
• Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c
• Vislink Technologies Inc. (VISL) Misses Q2 EPS by 7c